Katherine Baumgarten is an Infectious Disease physician affiliated with Ochsner Health System. OpenAlex indexes 19 publications with 1,047 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1514 Jefferson Hwy
New Orleans, LA 701212429
Telephone
504-842-4000Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20233 payments
- STERIS CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
49.6%Statin22.1%Atorvastatin Calcium53%Rosuvastatin Calcium47%Part D<11 patientsACE inhibitor13.2%Lisinopril61%Benazepril-Hydrochlorothiazide39%Part D<11 patients+ 2 more classes in this area
Anti-infectives
27.9%Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor8.5%Efavirenz-Emtric-Tenofov Disop100%Part D<11 patientsTetracycline-class Drug6.6%Doxycycline Hyclate100%Part D≥12 patients+ 3 more classes in this area
Nervous system
18%Benzodiazepine9.2%Alprazolam52%Diazepam48%Part D<11 patientsSSRI8.8%Paroxetine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
Clinical Infectious Diseases
2024 - The effects of a novel, continuous disinfectant technology on methicillin-resistant Staphylococcus aureus (MRSA), fungi, and aerobic bacteria in 2 separate intensive care units in 2 different states: An experimental design with observed impact on health care associated infections (HAIs)
American Journal of Infection Control
2024 - Erratum to “The effects of a novel, continuous disinfectant technology on methicillin-resistant Staphylococcus aureus (MRSA), fungi, and aerobic bacteria in 2 separate intensive care units in 2 different states: An experimental design with observed impact” [Am J Infect Control 52 (2024) 884–892]
American Journal of Infection Control
2024 - Exploring the relationship between the reduction of floor microbial burden and the impact on healthcare-associated infections
Antimicrobial Stewardship & Healthcare Epidemiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carl Lavie, MD
Ochsner Health System
Natalie Bzowej, MD
Ochsner Health System
Mark Effron, MD
Ochsner Health System
Jane Martin, MD
Ochsner Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”